Literature DB >> 27868135

A review of bioresorbable scaffolds: hype or hope?

Huay Cheem Tan1, Rajiv Ananthakrishna1.   

Abstract

In the field of percutaneous coronary intervention, the evolution of coronary metal stents has been well established for the past three decades, but research on bioresorbable scaffolds has only gained momentum in the recent past. Although second-generation drug-eluting metal stents are the gold standard for the treatment of obstructive coronary artery disease, a few drawbacks exist. The development of bioresorbable scaffolds is an attempt to overcome the limitations of metal stents. This review highlights the rationale for the bioresorbable scaffold, its properties and potential applications. It also focuses on the current evidence and concerns regarding the application of the bioresorbable scaffold in day-to-day practice. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  bioresorbable scaffold; coronary artery disease

Mesh:

Substances:

Year:  2016        PMID: 27868135      PMCID: PMC5605821          DOI: 10.11622/smedj.2016178

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  44 in total

Review 1.  Design principles and performance of bioresorbable polymeric vascular scaffolds.

Authors:  James P Oberhauser; Syed Hossainy; Richard J Rapoza
Journal:  EuroIntervention       Date:  2009-12-15       Impact factor: 6.534

2.  Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.

Authors:  Serban Puricel; Diego Arroyo; Noé Corpataux; Gérard Baeriswyl; Sonja Lehmann; Zacharenia Kallinikou; Olivier Muller; Ludovic Allard; Jean-Christophe Stauffer; Mario Togni; Jean-Jacques Goy; Stéphane Cook
Journal:  J Am Coll Cardiol       Date:  2015-03-03       Impact factor: 24.094

3.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

4.  The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled.

Authors:  Alexandre Abizaid; J Ribamar Costa; Antonio L Bartorelli; Robert Whitbourn; Robert Jan van Geuns; Bernard Chevalier; Tejas Patel; Ashok Seth; Marrianne Stuteville; Cécile Dorange; Wai-Fung Cheong; Krishnankutty Sudhir; Patrick W Serruys
Journal:  EuroIntervention       Date:  2015-04       Impact factor: 6.534

5.  Treatment of coronary in-stent restenosis with bioabsorbable vascular scaffolds.

Authors:  Fernando Alfonso; Julio Nuccio; Cecilia Cuevas; Alberto Cárdenas; Nieves Gonzalo; Pilar Jimenez-Quevedo
Journal:  J Am Coll Cardiol       Date:  2014-07-01       Impact factor: 24.094

6.  Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.

Authors:  H Tamai; K Igaki; E Kyo; K Kosuga; A Kawashima; S Matsui; H Komori; T Tsuji; S Motohara; H Uehata
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

7.  Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents.

Authors:  Soji Nishio; Kunihiko Kosuga; Keiji Igaki; Masaharu Okada; Eisho Kyo; Takafumi Tsuji; Eiji Takeuchi; Yasutaka Inuzuka; Shinsaku Takeda; Tatsuhiko Hata; Yuzo Takeuchi; Yoshitaka Kawada; Takeshi Harita; Junya Seki; Shunji Akamatsu; Shinichi Hasegawa; Nico Bruining; Salvatore Brugaletta; Sebastiaan de Winter; Takashi Muramatsu; Yoshinobu Onuma; Patrick W Serruys; Shigeru Ikeguchi
Journal:  Circulation       Date:  2012-04-16       Impact factor: 29.690

Review 8.  Vascular responses to drug eluting stents: importance of delayed healing.

Authors:  Aloke V Finn; Gaku Nakazawa; Michael Joner; Frank D Kolodgie; Erik K Mont; Herman K Gold; Renu Virmani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-17       Impact factor: 8.311

9.  Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.

Authors:  Shuzou Tanimoto; Patrick W Serruys; Leif Thuesen; Dariusz Dudek; Bernard de Bruyne; Bernard Chevalier; John A Ormiston
Journal:  Catheter Cardiovasc Interv       Date:  2007-10-01       Impact factor: 2.692

10.  Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.

Authors:  Takashi Muramatsu; Yoshinobu Onuma; Hector M García-García; Vasim Farooq; Christos V Bourantas; Marie-Angèle Morel; Xiaolin Li; Susan Veldhof; Antonio Bartorelli; Robert Whitbourn; Alexandre Abizaid; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2013-03       Impact factor: 11.195

View more
  1 in total

1.  Atomic Layer Deposition Coating of TiO2 Nano-Thin Films on Magnesium-Zinc Alloys to Enhance Cytocompatibility for Bioresorbable Vascular Stents.

Authors:  Fan Yang; Run Chang; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2019-12-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.